Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Adverum Biotechnologies (ADVM)

Adverum Biotechnologies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADVM
DateTimeSourceHeadlineSymbolCompany
09/05/202421:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADVMAdverum Biotechnologies Inc
09/05/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADVMAdverum Biotechnologies Inc
09/05/202421:05GlobeNewswire Inc.Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline HighlightsNASDAQ:ADVMAdverum Biotechnologies Inc
03/05/202413:00GlobeNewswire Inc.Adverum Biotechnologies to Participate in Upcoming May Investor ConferencesNASDAQ:ADVMAdverum Biotechnologies Inc
25/04/202421:05GlobeNewswire Inc.Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific MeetingNASDAQ:ADVMAdverum Biotechnologies Inc
18/03/202420:05GlobeNewswire Inc.Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate UpdatesNASDAQ:ADVMAdverum Biotechnologies Inc
04/03/202421:40Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ADVMAdverum Biotechnologies Inc
28/02/202421:05GlobeNewswire Inc.Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:ADVMAdverum Biotechnologies Inc
22/02/202420:47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADVMAdverum Biotechnologies Inc
21/02/202420:39Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ADVMAdverum Biotechnologies Inc
15/02/202421:17Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADVMAdverum Biotechnologies Inc
15/02/202401:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADVMAdverum Biotechnologies Inc
14/02/202421:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADVMAdverum Biotechnologies Inc
14/02/202421:30Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADVMAdverum Biotechnologies Inc
14/02/202421:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADVMAdverum Biotechnologies Inc
14/02/202421:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADVMAdverum Biotechnologies Inc
12/02/202413:00GlobeNewswire Inc.Adverum Biotechnologies to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:ADVMAdverum Biotechnologies Inc
09/02/202422:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADVMAdverum Biotechnologies Inc
09/02/202416:41Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADVMAdverum Biotechnologies Inc
08/02/202413:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADVMAdverum Biotechnologies Inc
08/02/202412:00GlobeNewswire Inc.Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMDNASDAQ:ADVMAdverum Biotechnologies Inc
06/02/202421:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADVMAdverum Biotechnologies Inc
05/02/202422:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADVMAdverum Biotechnologies Inc
05/02/202412:45GlobeNewswire Inc.Adverum Biotechnologies Announces $127.5 Million Private Placement FinancingNASDAQ:ADVMAdverum Biotechnologies Inc
01/02/202422:30GlobeNewswire Inc.Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Results on February 8, 2024NASDAQ:ADVMAdverum Biotechnologies Inc
29/01/202413:00GlobeNewswire Inc.Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific OfficerNASDAQ:ADVMAdverum Biotechnologies Inc
08/12/202321:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADVMAdverum Biotechnologies Inc
07/12/202321:05GlobeNewswire Inc.Adverum Biotechnologies to Present LUNA Preliminary Efficacy and Safety Data at the 47th Annual Meeting of the Macula SocietyNASDAQ:ADVMAdverum Biotechnologies Inc
04/12/202321:09Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ADVMAdverum Biotechnologies Inc
28/11/202321:05GlobeNewswire Inc.Adverum Biotechnologies to Participate in the Evercore ISI 6th Annual HealthCONx ConferenceNASDAQ:ADVMAdverum Biotechnologies Inc
 Showing the most relevant articles for your search:NASDAQ:ADVM

Your Recent History

Delayed Upgrade Clock